Astrazeneca (AZN) P/S (1999 - 2026)
Astrazeneca (AZN) P/S from Nov 1, 1999 to Jul 20, 2026. The TTM Astrazeneca (AZN) P/S is 4.25. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Astrazeneca (AZN)
| Year | P/S | Change |
|---|---|---|
| 2026 | 4.25 | -13.15% |
| 2025 | 4.89 | +29.16% |
| 2024 | 3.79 | -18.95% |
| 2023 | 4.67 | -0.25% |
| 2022 | 4.68 | -2.80% |
| 2021 | 4.82 | -2.34% |
| 2020 | 4.93 | -8.08% |
| 2019 | 5.37 | +23.15% |
| 2018 | 4.36 | +10.36% |
| 2017 | 3.95 | +35.92% |
| 2016 | 2.90 | -16.45% |
| 2015 | 3.48 | +3.53% |
| 2014 | 3.36 | +15.78% |
| 2013 | 2.90 | +37.52% |
| 2012 | 2.11 | +12.48% |
| 2011 | 1.87 | -6.02% |
| 2010 | 2.00 | -3.78% |
| 2009 | 2.07 | +10.36% |
| 2008 | 1.88 | -10.99% |
| 2007 | 2.11 | +60.71% |
| 2006 | 1.31 | +4.63% |
| 2005 | 1.26 | +33.55% |
| 2004 | 0.94 | -24.78% |
| 2003 | 1.25 | +37.87% |
| 2002 | 0.91 | -24.70% |
| 2001 | 1.20 | -9.51% |
| 2000 | 1.33 | +23.35% |
| 1999 | 1.08 | N/A |
Comparison Astrazeneca (AZN) P/S with competitors
Astrazeneca (AZN) P/S is 4.25.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -86.46% |
| NVO | Novo Nordisk | 0.66 | -84.41% |
| GRFS | Grifols SA | 0.67 | -84.20% |
| AMRN | Amarin Corp | 1.39 | -67.26% |
| SCLX | Scilex Holding Company | 1.92 | -54.90% |
| SNY | Sanofi | 2.18 | -48.59% |
| PFE | Pfizer Inc | 2.18 | -48.59% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -43.50% |
| BIIB | Biogen Inc | 2.93 | -31.00% |
| GSK | GSK Plc | 3.22 | -24.07% |
| MRK | Merck & Co Inc | 4.54 | +6.83% |
| NVS | Novartis AG | 5.07 | +19.40% |
| AMGN | AMGEN Inc | 5.15 | +21.29% |
| GILD | Gilead Sciences Inc | 5.43 | +27.88% |
| JNJ | Johnson & Johnson | 6.34 | +49.31% |
| ABBV | Abbvie Inc | 7.15 | +68.39% |
| LLY | Lilly(Eli) & Company | 14.28 | +236.31% |